Skip to main content

Table 2 Epicardial fat volume, echocardiographic, and laboratory parameters of study patients

From: Predictors of improvement in left ventricular systolic function after catheter ablation in patients with persistent atrial fibrillation complicated with heart failure

 

I group(n = 60)

NI group(n = 20)

P -value

TTE

   

LVEF(%)

41.4 ± 4.8

43.3 ± 5.0

0.131

LAD(mm)

45.4 ± 4.5

45.7 ± 4.7

0.822

E/A (m/s)

1.17 ± 0.42

1.19 ± 0.44

0.084

LVDd(mm)

54.30 ± 5.02

58.95 ± 6.66

0.001

Laboratory parameters

   

NT-pro BNP(pg/ml)

2228(1251,3850)

2350(608,5994)

0.731

Hs-CRP(mg/dL)

1.25(0.50,2.98)

1.10(0.50,5.78)

0.946

e-GFR(ml/min/1.73\({m}^{2}\))

101.4(82.5,119.9)

91.2(69.0,100.7)

0.008

Creatinine(u mol/L)

69.25 ± 14.90

76.90 ± 15.13

0.051

Hb(g/L)

145.7 ± 17.2

138.2 ± 18.5

0.099

TC(mmol/L)

3.97 ± 0.87

3.73 ± 0.82

0.286

TG(mmol/L)

1.17(0.93,1.54)

1.13(0.90,1.78)

0.881

LDL-C(mmol/L)

2.39(1.73,2.74)

2.18(1.49,2.75)

0.519

HDL-C(mmol/L)

1.02 ± 0.22

0.93 ± 0.17

0.089

Epicardial adipose tissue

   

Total-EAT volume (cm3)

106.22(88.44,133.08)

101.02(85.81,145.41)

0.885

LA-EAT volume (cm3)

26.08(18.51,30.91)

28.54(19.92,40.47)

0.386

LVZs n(%)

19(31.7)

14(70.0)

0.003

Recurrence of AF n(%)

11(18.3)

4(20.0)

0.869

  1. I group = improve group, NI group = nonimprove group, LA-EAT = left atrial epicardial adipose tissue, TTE = transthoracic echocardiogram, LVEF = left ventricular ejection fractions, LAD = left atrial diameter, LVDd = left ventricular end diastolic diameter, LVZs = low voltage zones